Pacific Biosciences Of California Operating Income 2010-2023 | PACB

Pacific Biosciences Of California operating income from 2010 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Pacific Biosciences Of California Annual Operating Income
(Millions of US $)
2023 $-334
2022 $-307
2021 $-210
2020 $-104
2019 $-101
2018 $-101
2017 $-90
2016 $-71
2015 $-29
2014 $-63
2013 $-78
2012 $-94
2011 $-110
2010 $-140
2009 $-88
Pacific Biosciences Of California Quarterly Operating Income
(Millions of US $)
2023-12-31 $-88
2023-09-30 $-82
2023-06-30 $-73
2023-03-31 $-91
2022-12-31 $-87
2022-09-30 $-75
2022-06-30 $-68
2022-03-31 $-78
2021-12-31 $-65
2021-09-30 $-74
2021-06-30 $-38
2021-03-31 $-34
2020-12-31 $-24
2020-09-30 $-24
2020-06-30 $-24
2020-03-31 $-33
2019-12-31 $-18
2019-09-30 $-28
2019-06-30 $-24
2019-03-31 $-30
2018-12-31 $-31
2018-09-30 $-25
2018-06-30 $-22
2018-03-31 $-24
2017-12-31 $-21
2017-09-30 $-22
2017-06-30 $-24
2017-03-31 $-23
2016-12-31 $-18
2016-09-30 $-17
2016-06-30 $-18
2016-03-31 $-19
2015-12-31 $-1
2015-09-30 $3
2015-06-30 $-11
2015-03-31 $-19
2014-12-31 $-18
2014-09-30 $-8
2014-06-30 $-18
2014-03-31 $-18
2013-12-31 $-17
2013-09-30 $-20
2013-06-30 $-20
2013-03-31 $-21
2012-12-31 $-22
2012-09-30 $-23
2012-06-30 $-23
2012-03-31 $-28
2011-12-31 $-23
2011-09-30 $-29
2011-06-30 $-23
2011-03-31 $-35
2010-12-31 $-37
2010-09-30 $-41
2010-06-30 $-33
2010-03-31 $-30
2009-12-31
2009-09-30 $-25
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.415B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $207.950B 25.29
Intuitive Surgical (ISRG) United States $129.849B 78.28
Edwards Lifesciences (EW) United States $51.730B 34.24
DexCom (DXCM) United States $50.391B 86.56
IQVIA Holdings (IQV) United States $41.398B 24.55
IDEXX Laboratories (IDXX) United States $39.563B 47.30
Alcon (ALC) Switzerland $39.226B 28.93
STERIS (STE) Ireland $19.714B 23.33
Hologic (HOLX) United States $17.694B 19.53
Waters (WAT) United States $17.562B 25.20
SONOVA HOLDING (SONVY) Switzerland $16.183B 0.00
ShockWave Medical (SWAV) United States $12.304B 85.01
Fresenius Medical Care AG KGaA (FMS) Germany $11.467B 14.16
Teleflex (TFX) United States $9.729B 15.28
Sysmex ADR (SSMXY) Japan $9.453B 29.64
Penumbra (PEN) United States $7.846B 97.00
Masimo (MASI) United States $7.131B 39.99
Globus Medical (GMED) United States $6.816B 21.61
Glaukos (GKOS) United States $4.843B 0.00
Integer Holdings (ITGR) United States $3.907B 24.97
LivaNova (LIVN) United Kingdom $2.824B 18.62
TransMedics (TMDX) United States $2.753B 0.00
Elekta AB (EKTAY) Sweden $2.581B 17.71
PROCEPT BioRobotics (PRCT) United States $2.558B 0.00
Nihon Kohden (NHNKY) Japan $2.327B 19.68
Integra LifeSciences Holdings (IART) United States $2.254B 9.25
Inari Medical (NARI) United States $2.237B 385.90
Tandem Diabetes Care (TNDM) United States $1.965B 0.00
RxSight (RXST) United States $1.908B 0.00
Alphatec Holdings (ATEC) United States $1.730B 0.00
Veracyte (VCYT) United States $1.460B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.864B 15.99
OPKO Health (OPK) United States $0.857B 0.00
Artivion (AORT) United States $0.825B 95.38
Paragon 28 (FNA) United States $0.812B 0.00
OrthoPediatrics (KIDS) United States $0.721B 0.00
Silk Road Medical (SILK) United States $0.679B 0.00
Treace Medical Concepts (TMCI) United States $0.677B 0.00
SiBone (SIBN) United States $0.633B 0.00
Mesa Laboratories (MLAB) United States $0.543B 18.45
IRadimed (IRMD) United States $0.519B 30.15
ORTHOFIX MEDICAL INC (OFIX) United States $0.490B 0.00
Nevro (NVRO) United States $0.443B 0.00
Pulse Biosciences (PLSE) United States $0.397B 0.00
NeuroPace (NPCE) United States $0.367B 0.00
Tactile Systems Technology (TCMD) United States $0.342B 11.52
CVRx (CVRX) United States $0.322B 0.00
AxoGen (AXGN) United States $0.284B 0.00
EDAP TMS S.A (EDAP) France $0.269B 0.00
Sight Sciences (SGHT) United States $0.254B 0.00
AngioDynamics (ANGO) United States $0.251B 0.00
Accuray (ARAY) United States $0.212B 0.00
908 Devices (MASS) United States $0.184B 0.00
Semler Scientific (SMLR) United States $0.181B 9.75
Alpha Tau Medical (DRTS) Israel $0.178B 0.00
Atossa Genetics (ATOS) United States $0.172B 0.00
Inogen (INGN) United States $0.157B 0.00
ClearPoint Neuro (CLPT) United States $0.144B 0.00
Delcath Systems (DCTH) United States $0.124B 0.00
Neuronetics (STIM) United States $0.114B 0.00
Yubo Biotech (YBGJ) China $0.112B 0.00
Envoy Medical (COCH) United States $0.099B 0.00
KORU Medical Systems (KRMD) United States $0.095B 0.00
Spectral Diagnostics (EDTXF) Canada $0.086B 0.00
Monogram Orthopaedics (MGRM) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
Hyperfine (HYPR) United States $0.060B 0.00
Autonomix Medical (AMIX) United States $0.056B 0.00
Vasomedical (VASO) United States $0.055B 9.83
Sensus Healthcare (SRTS) United States $0.054B 109.67
Vicarious Surgical (RBOT) United States $0.051B 0.00
InspireMD (NSPR) Israel $0.049B 0.00
SEP Acquisition (SEPA) United States $0.049B 0.00
Aspira Women's Health (AWH) United States $0.043B 0.00
ReWalk Robotics (LFWD) Israel $0.041B 0.00
Lucid Diagnostics (LUCD) United States $0.038B 0.00
Rapid Micro Biosystems (RPID) United States $0.038B 0.00
Pixie Dust Technologies (PXDT) Japan $0.037B 0.00
LENSAR (LNSR) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.034B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.032B 0.00
Ekso Bionics Holdings (EKSO) United States $0.024B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.023B 0.00
Accelerate Diagnostics (AXDX) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.018B 0.00
PAVmed (PAVM) United States $0.017B 0.00
T2 Biosystems (TTOO) United States $0.016B 0.00
Biosig Technologies (BSGM) United States $0.016B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Microbot Medical (MBOT) United States $0.012B 0.00
Avinger (AVGR) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
Helius Medical Technologies (HSDT) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00